Cipher Pharmaceuticals Profit Margin

The latest profit margin for CPHRF is 58.8% as of June 2026. That compares with 25.52% in the prior-year period — up 130.4% year over year. That is above the Healthcare sector average of 14.41%. Investors often review this figure alongside Cipher Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, CPHRF's profit margin moved from 25.52% to 58.8% — a 130.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cipher Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, CPHRF currently prints 58.8% for profit margin, while the sector average sits near 14.41%. That is roughly 307.9% above the sector mean. Large gaps often invite a closer look at Cipher Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Cipher Pharmaceuticals converts resources into returns. At 58.8%, CPHRF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 25.52% in the prior-year period — up 130.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CPHRF's profit margin (58.8%), review year-over-year change from 25.52%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.